Sony To Use iPS Cell Analyzer To Plunge Into Medical-Device Industry
This article was originally published in PharmAsia News
Executive Summary
Sony plans to draw on its digital-electronics expertise to enter the medical-equipment business in a big way by reducing the amount of time it takes to develop cultured cells into commercialized regenerative medicine.